a ban on transgender athletes last year.The most prominent of the bills is a measure to ban transgender youth from accessing gender-affirming treatments meant to treat gender dysphoria, including puberty blockers, hormones, or surgical interventions, the latter of which are rarely performed on minors.The ban on gender-affirming care appeared to be dead last month after Sen. Fred Mills (R-New Iberia, the chairman of the Senate Health and Welfare Committee, voted with Democrats to reject the bill when it came before the committee. Mills said that his decision had been heavily influenced by a 2022 Louisiana Health Department study on gender-affirming health care.It found that no gender-affirming surgical procedures had been performed on any minors enrolled in Medicaid in the state between 2017 and 2021, and that hormone and puberty blockers were rarely prescribed to transgender-identifying minors in Louisiana during that same period. National conservative pundits — who have deemed opposition to LGBTQ visibility, transgender rights, and “wokeness” as essential to their party’s brand — were outraged at Mills’ defection, and promised political retribution.Mills’ fellow Republicans caved to pressure from those voices to revive the bill.Senators then used a rare procedural maneuver to recommit the bill to a different committee, allowing it to pass on a 29-10 vote, reports the Associated Press.The bill now heads back to the House, which previously overwhelmingly approved the ban on gender-affirming care.
